期刊文献+

药源性急性胰腺炎及其相关药物 被引量:3

Drug-induced Acute Pancreatitis and Related Drugs
下载PDF
导出
摘要 药源性急性胰腺炎是药物诱发的一种医源性消化道急症。药源性急性胰腺炎尽管比较少见,但为了提高临床用药安全性,应加强对药源性急性胰腺炎临床表现及相关药物的监测。现就利尿药、甾体类激素、非甾体类抗炎药物、抗菌药物、抗肿瘤药物、中枢神经系统药物、心血管药物、中草药等10余种药物诱发的胰腺炎的发病机制、罹病药物、临床表现及诊断治疗要点等进行阐述。 As one of iatrogenic acute gastrointestinal complications, drug-induced acute panereatitis (DAP) is not seen commonly, whose manifestations should he carefully observed for the safety of drug administration.This review was focused on the mechanisms,clinical manifestations,diagnosis and treatment of DAP induced by various drugs, including diuretics, steroid hormones, non-steroidal anti-inflammatory drugs, antibiotics, anticancer drugs, central nervous system drugs, cardiovascular drugs,herbs, and so forth.
作者 范照冬
出处 《医学综述》 2008年第5期760-762,共3页 Medical Recapitulate
关键词 药源性急性胰腺炎 不良反应 药源性疾病 Drug-induced acute pancreatitis Adverse reaction Drug-induced diseases
  • 相关文献

参考文献2

二级参考文献32

  • 1[1]Lankisch PG,Droge M,Gottesleben F.Drug induced acute pancreatitis:incidence and severity.Gut 1995; 37:565-567
  • 2[2]Mallory A,Kern F.Drug-induced pancreatitis.Baillieres Clin Gastroenterol 1988; 2:293-307
  • 3[3]Runzi M,Layer P.Drug-associated pancreatitis:facts and fiction.Pancreas 1996; 13:100-109
  • 4[4]Anagnostopoulos GK,Tsiakos S,Margantinis G,Kostopoulos P,Arvanitidis D.Acute pancreatitis due to pravastatin therapy.JOP 2003; 4:129-132
  • 5[5]Pluhar W.A case of possible lovastatin-induced pancreatitis in concomitant Gilbert syndrome.Wien Klin Wochenschr 1989;101:551-554
  • 6[6]Ramdani M,Schmitt AM,Liautard J,Duhamel O,Legroux P,Gislon J,Pariente EA,Agay D,Faure D.Simvastatin-induced acute pancreatitis:two cases.Gastroenterol Clin Biol 1991; 15:986
  • 7[7]Lons T,Chousterman.M.Simvaytatin:a new drug responsible for acute pancreatitis? Gastroenterol Clin Biol 1991; 15:93-94
  • 8[8]Abdul-Ghaffar NU,el-Sonbaty MR.Pancreatitis and rhabdomyolysis associated with lovastatin-gemfibrozil therapy.J Clin Gastroenterol 1995; 21:340-341
  • 9[9]Hunninghake D,Bakker-Arkema RG,Wigand JP,Drehobl M,Schrott H,Early JL,Abdallah P,McBride S,Black DM.Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin,fluvastatin,lovastatin,or simvastatin in patients with risk factors for coronary heart disease.J Fam Pract 1998; 47:349-356
  • 10[10]Wong PW,Dillard TA,Kroenke K.Multiple organ toxicity from addition of erythromycin to long-term lovastatin therapy.South Med J 1998; 91:202-205

共引文献5

同被引文献60

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部